engleski

Comparison of Verisyse and Veriflex Phakic intraocular lenses for treatment of moderate to high myopia 36 months after surgery

To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome ; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.

endothelial cells count loss ; veriflex ; verisyse ; myopia ; phakic intraocular lenses

nije evidentirano